Skip to main content
SpringerLink
Log in

Expanding HCV treatment access in primary care cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Extension for Community Healthcare Outcomes

  2. 2015 US dollars

Reference

  • Rattay T, et al. Cost-effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers. Gastroenterology : 23 Oct 2017. Available from: URL: http://doi.org/10.1053/j.gastro.2017.10.016

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Expanding HCV treatment access in primary care cost effective. PharmacoEcon Outcomes News 791, 15 (2017). https://doi.org/10.1007/s40274-017-4499-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4499-1

Search

Navigation